ARDX
Ardelyx, Inc. · Healthcare
Chief Development Officer David P. Rosenbaum sold $162K of Ardelyx, Inc.
Sold$161,673
$5.95Price
27,172Shares
−5%Stake
What ARDX did after the filing
- The stock from Wed, Nov 6 close, $6.49
- −27.7%
- S&P 500, same days
- −0.8%
Measured over 30 trading days, to the Dec 19 close.
Traded Mon, Nov 4. Filed Wed, Nov 6, 12:59 PM ET, during the session. Returns use the Nov 6 close and the Dec 19 close. Not investment advice.